Entrepreneurs raise DKK 10 million to help sperm quality test penetrate lucrative US market
Valby-based company Motilitycount, which obtained FDA approval for its sperm quality test last year, has raised DKK 10 million (USD 1.4 million) through new investors and debt conversion. The money makes it possible for the company to go from being a startup to a scaleup firm, the CEO says.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY CATHERINE BRETT
Avoid a trip to the doctor or fertility clinic.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
